Cargando…
Pharmacotherapy in the management of early Parkinson’s disease: cost-effectiveness and patient acceptability
In the absence of a cure, the primary goals in managing Parkinson’s disease (PD) are to preserve functionality and health-related quality of life (HRQoL). Current therapeutic strategies for PD include symptomatic treatment and are primarily focused on replacing dopamine in the brain. Dopamine agonis...
Autor principal: | Cubo, Esther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169957/ https://www.ncbi.nlm.nih.gov/pubmed/21935322 http://dx.doi.org/10.2147/CEOR.S11996 |
Ejemplares similares
-
Novel Pharmacotherapies in Parkinson’s Disease
por: Tizabi, Yousef, et al.
Publicado: (2021) -
Global Perspective on Telemedicine for Parkinson’s Disease
por: Shalash, Ali, et al.
Publicado: (2021) -
Telemedicine in the Management of Parkinson’s Disease: Achievements, Challenges, and Future Perspectives
por: Cubo, Esther, et al.
Publicado: (2022) -
Modified Iron Deposition in Nigrosomes by Pharmacotherapy for the Management of Parkinson’s Disease
por: Wang, Mengdi, et al.
Publicado: (2022) -
Drug Interactions in Parkinson’s Disease: Safety of Pharmacotherapy for Arterial Hypertension
por: Bitner, Anna, et al.
Publicado: (2015)